奇正藏药：公司2025年暂未推出新药

Core Viewpoint - The company has not launched any new drugs in 2025, but it is progressing with the clinical trials of a new drug for children, which received approval from the National Medical Products Administration [1] Group 1: New Drug Development - The company’s new drug, Pediatric Re-Liqing Granules, received the Clinical Trial Approval Notice from the National Medical Products Administration in May 2025 [1] - The clinical trials for this drug will focus on treating acute upper respiratory infections with wind-heat and dampness syndrome in children [1] - The company plans to conduct Phase II and III clinical trials and will compile the necessary documentation for product registration [1] Group 2: Future Reporting - The company will provide updates on the progress of other in-development products in its semi-annual report scheduled for release on August 23, 2025 [1]